Kent Leyde is the founder of Cadence Neuroscience. Cadence Neuroscience has raised $41M in total funding. Latest round: Series B.
Kent Leyde is the CEO and founder of Cadence Neuroscience, a clinical-stage medical device startup developing an implantable neuromodulation therapy for focal drug-resistant epilepsy. He has led the company since its founding in 2017, overseeing significant funding rounds to advance clinical studies and pursue FDA clearance.
Full founder directory · Investor directory · Company funding database · Fundraising library